Effects of full-dose heparin anticoagulation on the development of left ventricular thrombosis in acute transmural myocardial infarction
P Gueret,
O Dubourg,
A Ferrier,
JC Farcot,
M Rigaud,
and
JP Bourdarias
The incidence of left ventricular thrombosis after acute transmural myocardial infarction has been evaluated with two-dimensional echocardiography. To assess the preventive action of early anticoagulation with full-dose heparin, 90 patients, admitted within 5.2 +/- 4.6 hours after the onset of symptoms of their first episode of acute myocardial infarction (46 anterior and 44 inferior), were prospectively studied. Patients were randomly assigned either to therapeutic anticoagulation with heparin or to no anticoagulant therapy. Serial two-dimensional echocardiograms were recorded on the day of admission, the next day, days 4 to 7 and days 20 to 50 to detect left ventricular thrombus and to assess global left ventricular performance. On the first echocardiogram (10.3 +/- 8.0 hours after the onset of symptoms) no thrombus was visualized. In 44 patients with inferior myocardial infarction (23 receiving heparin and 21 not receiving heparin) no further left ventricular thrombus developed. In 46 patients with anterior myocardial infarction, 21 additional thrombi developed (45.6%) within 4.3 +/- 3.0 days after the acute event. Thrombus developed in 8 (38%) of 21 patients receiving heparin, compared with 13 (52%) of 25 patients not receiving heparin. This difference in ventricular thrombosis was not statistically significant (chi-square with the Yates correction = 0.76; NS). No difference was found between the subgroups in terms of clinical variables, infarct size, hemodynamic impairment, intensity of the inflammatory process and quantitative two-dimensional echocardiographic and cineangiographic left ventricular function. It is concluded that early anticoagulation with heparin reduced by 27% the incidence of left ventricular thrombus formation in anterior acute transmural myocardial infarction, and this relative risk reduction was not statistically significant when compared with findings in the untreated group.
This article has been cited by other articles:
|
|
|
|
 
J. A. Cairns, P. Theroux, H. D. Lewis Jr., M. Ezekowitz, and T. W. Meade
Antithrombotic Agents in Coronary Artery Disease
Chest,
January 1, 2001;
119(1_suppl):
228S - 252S.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al.
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)
J. Am. Coll. Cardiol.,
June 1, 1999;
33(7):
2092 - 2197.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Cheitlin, J. S. Alpert, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, T. W. Davidson, J. L. Davis, P. S. Douglas, L. D. Gillam, et al.
ACC/AHA Guidelines for the Clinical Application of Echocardiography : A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) Developed in Collaboration With the American Society of Echocardiography
Circulation,
March 18, 1997;
95(6):
1686 - 1744.
[Full Text]
|
|
|
|
|
|
|
R. Collins, S. MacMahon, M. Flather, C. Baigent, L. Remvig, S. Mortensen, P. Appleby, J. Godwin, S. Yusuf, and R. Peto
Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials
BMJ,
September 14, 1996;
313(7058):
652 - 659.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. K. Batra, M. D. Adolph, J. C. Thornton, A. M. Byramjee, A. O. Oliver, and H. Schreiber
Antithrombin III Deficiency and White Clot Syndrome: Case Reports and Literature Review
Vascular and Endovascular Surgery,
January 1, 1996;
30(1):
37 - 44.
[Abstract]
[PDF]
|
|
|
|
